Hemorrex^® (Suppositories) Instructions for Use

Marketing Authorization Holder

YUGPHARM, LLC (Russia)

ATC Code

B02BC (Local hemostatics)

Active Substance

Sodium alginate (Ph.Eur. European Pharmacopoeia)

Dosage Form

Hemorrex^®

Rectal suppositories 250 mg: 5, 10, or 15 pcs.

Dosage Form, Packaging, and Composition

Rectal suppositories white or almost white, or white with a brownish tint, or light brown, or light gray with a brownish tint, or pale yellow, or pale yellowish-brown in color, torpedo-shaped; the appearance of a coating on the surface of the suppository and the presence of an air core on the cut or a funnel-shaped depression at the base are allowed.

	1 supp.
Sodium alginate	250 mg

Excipients: hard fat – up to a suppository mass of 2250 mg.

5 pcs. – contour cell packs (1) – cardboard boxes.
5 pcs. – contour cell packs (2) – cardboard boxes.
5 pcs. – contour cell packs (3) – cardboard boxes.

Clinical-Pharmacological Group

Drug with hemostatic, anti-inflammatory, and wound-healing action for topical use in proctology

Pharmacotherapeutic Group

Hemostatic agents; vitamin K and other hemostatic agents; topical hemostatic agents

Pharmacological Action

A hemostatic drug for topical use. It is a natural polysaccharide obtained from brown seaweed. It has a pronounced hemostatic effect and possesses anti-inflammatory and reparative properties.

Indications

Anal fissures in the epithelialization stage
Chronic bleeding hemorrhoids
Proctosigmoiditis
Inflammation of the rectum in the postoperative period

ICD codes

Open the list of ICD codes

ICD-10 code	Indication
K60	Fissure and fistula of anus and rectum
K62.8	Other specified diseases of anus and rectum (including proctitis)
K64	Hemorrhoids and perianal venous thrombosis

ICD-11 code	Indication
DB50.Z	Fissure or fistula of anal region, unspecified
DB6Z	Hemorrhoids or perianal venous diseases, unspecified
DB70.Z	Infections of anal and rectal regions, unspecified
DB72.Z	Some specified diseases of the anal canal, unspecified
DE2Z	Diseases of the digestive system, unspecified
EG61	Infections of the anus or perianal skin

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer one suppository rectally twice daily, typically in the morning and evening.

The standard treatment duration is 7 to 14 days.

Adjust the course length based on the severity of the disease and the clinical response observed.

Adverse Reactions

Adverse reactions are uncommon.

Allergic reactions, including localized skin reactions such as itching, redness, or rash, are possible.

Discontinue use immediately and consult a physician if any signs of hypersensitivity appear.

Contraindications

Hypersensitivity to sodium alginate or any of the excipients listed in the composition.

Use in Pregnancy and Lactation

Rectal use during pregnancy and lactation is possible as indicated.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer